RaviKiranKodeMD

PubMed

• Nine year experience with kidney transplantation in patients with positive hepatitis C virus antibody.
  Kode, R. K., Foster, C. E., Kumar, A. M., Vankawala, R., Damask, A. M., Fyfe, B. S., Seirka, D., Laftavi, M. R., Brezin, J., Pankewycz, O., Chvala, R., Kumar, M. S.> ;Transplant Proc. 2001 Feb 01
• Simulect, Neoral, Cellcept, and prednisone in kidney recipients with delayed graft function: a prospective controlled study.
  Kumar, M. S., Kode, R. K., Pankewycz, O. G., Laftavi, M. R., Kumar, A. M., Damask, A. M., Vora, M., Tomeny, M. B., Ferry, E., Samartino, B. C., Sierka, D., Lingaraju, ...> ;Transplant Proc. 2001 Nov 01
• Simulect, calcineurin inhibitor, mycophenolate mofetil, and prednisone is more effective than OKT3, calcineurin inhibitor, hycophendate mofetil, and prednisone in Afri...
  Kumar, A. M., Fa, K., Vankawala, R., Vora, M., Kode, R. K., Pankewycz, O. G., Lattavi, M. R., Fyfe, B., Damask, A. M., Ferry, E., Stabler, S., Tomeny, M. B., Phillips,...> ;Transplant Proc. 2001 Nov 01
• Induction strategy using basiliximab combined with mycophenolate MMF and immediate low-dose cyclosporin is steroid sparing and more effective than OKT3.
  Chowdhury, S., Kode, R. K., Ranganna, K., Damask, A. M., Lam, A., Fyfe, B., Stabler, S., Kumar, A. M., Tomeny, M. B., Kumar, M. S., Pankewycz, O.> ;Transplant Proc. 2001 Feb 01
• Simulect induction significantly decreases CMV infection in kidney recipients compared to OKT3.
  Kode, R. K., Kumar, A. M., Pankewycz, O., Damask, A. M., Seirka, D., Lam, A., Phillips, K., Ardron, M., Brezin, J., Chvala, R., Kumar, M. S.> ;Transplant Proc. 2001 Feb 01
• 15 citations
  Basiliximab plus low-dose cyclosporin vs. OKT3 for induction immunosuppression following renal transplantation.
  R.K Kode, Kosunarty Fa, Shoaib Chowdhury, Karthik Ranganna, Billie Fyfe, Susan Stabler, A.M Damask, Mark R. Laftavi, Anil Kumar, Oleh Pankewycz> ;Clinical Transplantation. 2003 Aug 1
• Join now to see all